Department of Chemistry and Biochemistry, University of California, La Jolla, San Diego, CA, 92093, USA.
J Biol Inorg Chem. 2018 Oct;23(7):1129-1138. doi: 10.1007/s00775-018-1593-1. Epub 2018 Jul 12.
Hydroxypyridinethiones (HOPTOs) are strong ligands for metal ions and potentially useful pharmacophores for inhibiting metalloenzymes relevant to human disease. However, HOPTOs have been sparingly used in drug discovery efforts due, in part, to concerns that this scaffold will act as a promiscuous, non-selective metalloenzyme inhibitor, as well as possess poor pharmacokinetics (PK), which may undermine drug candidates containing this functional group. To advance HOPTOs as a useful pharmacophore for metalloenzyme inhibitors, a library of 22 HOPTO isostere compounds has been synthesized and investigated. This library demonstrates that it is possible to maintain the core metal-binding pharmacophore (MBP) while generating diversity in structure, electronics, and PK properties. This HOPTO library has been screened against a set of four different metalloenzymes, demonstrating that while the same metal-binding donor atoms are maintained, there is a wide range of activity between metalloenzyme targets. Overall, this work shows that HOPTO isosteres are useful MBPs and valuable scaffolds for metalloenzyme inhibitors.
羟吡啶硫酮(HOPTOs)是金属离子的强配体,也是抑制与人类疾病相关的金属酶的潜在有用药效团。然而,由于担心该支架将作为一种混杂的、非选择性的金属酶抑制剂,以及具有较差的药代动力学(PK),因此 HOPTOs 在药物发现工作中很少被使用,这可能会破坏含有该功能团的候选药物。为了将 HOPTOs 推进为金属酶抑制剂的有用药效团,已经合成并研究了 22 种 HOPTO 等排化合物库。该库证明,在保持核心金属结合药效团(MBP)的同时,结构、电子和 PK 性质可以产生多样性。该 HOPTO 库已经针对四组不同的金属酶进行了筛选,表明虽然保持了相同的金属结合供体原子,但金属酶靶标之间的活性范围很广。总的来说,这项工作表明 HOPTO 等排物是有用的 MBP 和金属酶抑制剂的有价值的支架。